Neuropathy Detection System

A precision assessment tool based on international standard QST technology for evaluating small fiber neuropathy and early functional abnormalities in peripheral nerve pathology. The device provides comprehensive diagnostic evaluation for peripheral neuropathy and chronic pain management.

Integrated system for detecting and analyzing neurological conditions through biosignal analysis. Provides diagnostic support for neurological disease identification and monitoring.

Brain magnetic imaging platform for early-stage diagnosis of Alzheimer's disease and other neurodegenerative conditions. Detects functional changes in neural activity patterns associated with cognitive decline.

Non-invasive diagnostic tool for early detection of peripheral neuropathy in diabetic patients. Enables identification of nerve function abnormalities before clinical symptoms manifest.

Non-invasive screening device for early detection of diabetes and glucose metabolism disorders. Supports preventive healthcare and chronic disease management protocols.

Non-invasive diagnostic system designed for early detection of vascular complications in diabetic patients. Enables identification of arterial, venous, and lymphatic system abnormalities to prevent progression to diabetic foot syndrome.

Specialized pressure measurement system for identifying high-risk pressure areas in diabetic patients. Enables early detection of foot ulceration risk and preventive care planning.

A comprehensive diagnostic platform for assessing peripheral nerve function and small fiber neuropathy using quantitative sensory testing methodologies. The system addresses limitations of traditional nerve conduction studies in evaluating early functional abnormalities.

EMG/EP System for electromyography and evoked potential measurements used in neuromuscular and neurophysiological diagnostics. Enables detection and assessment of peripheral nerve, spinal cord, and muscle disorders through non-invasive electrical signal recording and analysis.

QST-100 is a quantitative sensory testing device for early screening of diabetic peripheral neuropathy using vibration perception threshold (VPT) measurement. It provides rapid, cost-effective assessment of small fiber neuropathy and chronic pain conditions, enabling detection of high-risk diabetic foot complications before advanced stages.

VIBRASENSE + T is a portable screening device for diabetic peripheral neuropathy (DPN) detection using vibration sensory testing. The compact diagnostic tool enables healthcare providers to assess nerve function and identify neuropathy early, supporting timely intervention and prevention of foot-related complications.

Electromyography and nerve conduction study systems for evaluating neuromuscular disorders and peripheral nerve function. Essential diagnostic tool for neurological conditions.